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Abstract 
Purpose 
Patients with alcohol-related disease constitute an increasing proportion of those admitted to ICU. 
There is currently limited evidence regarding the impact of alcohol use on levels of agitation, 
delirium and sedative requirements in ICU. This study aimed to determine whether ICU-admitted 
alcohol-abuse patients have different sedative requirements, agitation and delirium levels compared 
to patients with no alcohol issues. 
Methods 
This retrospective analysis of a prospectively-acquired database (June 2012 to May 2013) included 
257 patients. Subjects were stratified into three risk categories: alcohol dependency (n=69), at-risk 
(n=60) and low-risk (n=128) according to Fast Alcohol Screening Test (FAST) scores and WHO criteria 
for alcohol-related disease. Data on agitation and delirium was collected using validated 
retrospective chart-screening methods and sedation data was extracted  then log-transformed to fit 
the regression model. 
Results 
Incidence of agitation (p=0.034) and delirium (p=0.041) was significantly higher amongst alcohol-
dependent patients compared to low-risk patients as was likelihood of adverse events (p=0.007). In 
contrast, at-risk patients were at no higher risk of these outcomes compared to the low-risk group. 
Alcohol dependent patients experienced sub-optimal sedation levels more frequently and received a 
wider range of sedatives (p=0.019) but did not receive higher daily doses of any sedatives. 
Conclusions 
Our analysis demonstrates that when admitted to ICU, it is those who abuse alcohol most severely, 
alcohol dependent patients, rather than at-risk drinkers who have a significantly increased risk of 
agitation, delirium and sub-optimal sedation. These patients may require closer assessment and 
monitoring for these outcomes whilst admitted. 
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Introduction 
There has been a sustained rise in the numbers of high-risk alcohol users requiring admission to 
intensive care units (ICUs)[1] and alcohol-related disease is implicated in up to 25.4% of all 
admissions to Scottish ICUs [2;, 3]. These patients can be more difficult to maintain in a cooperative 
state, may develop alcohol withdrawal syndrome (AWS), have higher ICU mortality rates and poorer 
long-term outcomes [4-6]. 
The "ICU triad" of agitation, pain and delirium is increasingly recognised as being an important factor 
of a patient's ICU stay[7]. Traditionally, sedation has been utilised as a means of modulating patients' 
awareness of a potentially distressing environment, alleviating anxiety and facilitating interventions. 
However, if over-sedated, critically ill patients can be predisposed to prolonged time on ventilator 
support and longer ICU stays [8-10]. It is now well recognised that the implementation of sedation 
protocols which minimise overall sedative use result in reduced hospital stays and mortality[11;, 12]. 
Alcohol withdrawal syndrome typically occurs 6-8 hours following cessation of alcohol intake in the 
chronic alcohol user and can present with autonomic hyperactivity, hallucinations, agitation and 
seizures. There is overlap between AWS and delirium as both can present with hallucination and 
agitation. However, the aetiology of delirium is much broader and whereas, the treatment of AWS is 
primarily with benzodiazepines, delirium is treated with a multifactorial approach and drug 
treatment avoided where possible. 
Previous studies have examined the impact of agitation and delirium in the ICU setting. However, 
studies on how alcohol-abuse patients differ in terms of their agitation, delirium status and sedative 
management compared to low-risk controls are limited. From previous studies, estimates of the 
incidence of agitation in alcohol-abuse patients vary considerably from 12-72.7%[13] and there is 
conflicting evidence over sedation requirements in this cohort.  As far as we can establish, no study 
has comprehensively examined how these factors interact in patients with a history of alcohol use 
disorders (AUD) admitted to ICU. 
We aimed to determine if there is a difference in levels of agitation, delirium and sedative 
requirements between patients with alcohol-use disorders and those with no alcohol issues 
admitted to a general ICU. 
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Methods 
Ethics approval requirement was waived by the local ethics committee but Caldicott guardianship 
was sought and granted. This service evaluation provided a retrospective review of a prospectively-
acquired database of Level 3 ICU patients admitted to our unit over a 12-month period (June 2012 to 
May 2013). Level 3 ICU care refers to that of patients requiring multiple organ support or advanced 
respiratory support alone, as defined by the UK Intensive Care Society. This project took place in the 
Glasgow Royal Infirmary; a 20-bedded general mixed medical-surgical ICU, situated in an area of high 
socioeconomic deprivation where alcohol abuse is a known problem. 
Patients & Group Allocation 
Patients were included who were ≥18 years of age requiring Level 3 care. Patients were stratified 
into three risk categories based upon a composite scoring system on admission to the ICU: Low-risk, 
At-Risk and Alcohol Dependency (Appendix). Fast Alcohol Screening Test (FAST) scores were used if 
recorded prior to ICU admission during the present admission to hospital, or alternatively, by WHO 
ICD-10 classification for alcohol use disorders [14-16]. Patients' deemed 'at-risk' included those 
where identifiable physical or psychological harm resulted from alcohol use within the last 12 
months, whereas 'Alcohol Dependency' describes addictive behaviour to alcohol intake associated 
with tolerance, withdrawal and persistence despite harm. Presence of liver disease was determined 
according to either positive liver biopsy or imaging proven cirrhosis. These were recorded 
prospectively, on admission to hospital. For the purposes of this project only the sentinel admission 
was recorded. All data was extracted via the electronic patient records, CareVue (Philips Medical 
Systems, Eindhoven, the Netherlands) and WardWatcher (Critical Care Audit Ltd, Ilkley, UK).   
Matching 
Patients in the alcohol dependency and at-risk cohorts were matched to patients in the low-risk 
cohort according to their Acute Physiology and Chronic Health Evaluation II (APACHE-II) score and a 
diagnosis of sepsis during admission. This accounted for patients with higher disease severities 
potentially requiring greater sedation and both sepsis and high disease severity having been 
identified as significant independent risk factors for delirium and therefore, potential confounders 
[17].  
Clinical and demographic data was collected of patient's length of stay (LOS), age, gender, APACHE-II 
score, presence of liver disease and ICU survival status. 
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Agitation 
Agitation scores were recorded by nursing staff according to the Bloomsbury Sedation Scale 
(Appendix). This scale varies from -3 (unrousable) to 3 (agitated and restless). This data was 
extracted retrospectively and recorded for each day of admission. Agitation was defined as either a 
Bloomsbury sedation score of three or identification of a descriptor within the patient notes 
indicative of agitation using methodology previously described in the literature[18]. Adverse events, 
defined as either attempted or actual self-extubation, attempting to get out of bed or pulling at 
nasogastric (NG), nasojejunal (NJ) tubes or other lines, were recorded retrospectively using the 
chart-screening method. 
Delirium 
A validated chart-review method was undertaken to retrospectively screen for delirium, utilising 
detailed daily ward round and nursing notes. This method has a sensitivity of 74% when compared 
to the confusion assessment method (CAM) and is validated for use in the ICU setting, with a 
positive predictor accuracy of 87%[19;, 20].  Onset and duration of delirium in days, and evidence of 
reversibility (defined as delirium improving within one nursing shift equivalent to 12 hours) were 
recorded. Patients with a diagnosis of a chronic cognitive impairment such as dementia were 
excluded from the analysis of delirium. 
Sedation 
The total cumulative dosages each subject received of sedatives (propofol, dexemedetomidine, and 
clonidine), opioids (morphine, alfentanil, fentanyl and methadone), benzodiazepines (lorazepam, 
diazepam and temazepam) and haloperidol were collected and the average daily dose for each drug 
calculated. This included scheduled, stat and PRN doses and continuous IV infusions received. 
Benzodiazepines were converted into lorazepam equivalents and opioids into morphine equivalents 
[21;, 22]. Total number of individual sedative drugs and the administration of third line drugs 
(clonidine or dexemedetomidine) were recorded. 
 
Statistical Approach & Analysis 
Descriptive statistics were used to evaluate characteristics of agitation, delirium and aspects of 
sedative practice. Chi-squared and Fisher's Exact test were used for comparisons of categorical data. 
The 2-sample T-test and Mann-Whitney U test were used for comparisons of continuous data. 
Logistic regression was used for univariate analysis to calculate odds ratios for agitation, delirium 
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and adverse events, with adjustment for age and sex in multivariate analysis. Differences in sedative 
dosages were modelled using ANOVA. Univariate linear regression analysis was then used to 
compare the alcohol subgroups to the low-risk group, with adjustment for age and sex. Mean daily 
doses of all drugs were log transformed prior to fitting the regression model and coefficient 
estimates and 95% confidence intervals exponentiated to give the ratio of means.  Alcohol 
subgroups were compared to the low-risk cohort for analyses unless indicated. 
All analyses considered an alpha value of 0.05 as statistically significant and confidence intervals 
were calculated at the 95% level. All analyses were performed using statistical software SPPS Version 
21.0® (SPSS inc., Chicago, Illinois, USA). 
Results 
257 patients were included in final analysis: 128 in the low-risk group, 69 in the at-risk group and 60 
in the alcohol dependent group. Three patients were excluded due to a prior history of cognitive 
impairment. Patient characteristics are detailed in Table 1. Patients in the latter two groups were 
significantly younger, with a higher proportion of males and higher incidence of liver disease. 
Alcohol-dependent patients also had a longer LOS (9.9 vs 7.0 days, p=0.02). Mean APACHE-II score 
was 20.3 for all groups. 
Agitation & Adverse Events 
Incidence of agitation was significantly higher amongst alcohol dependent patients compared to the 
low-risk group (66.7% vs. 50.8%, p=0.034). Significance was retained after adjustment for age and 
gender. The at-risk group were no more likely to develop agitation than low-risk patients (Table 2). 
Agitation lasted for 2.5 days longer in the alcohol-dependence cohort compared to low-risk patients 
(median 5.5 vs. 3.0, p=0.005). 
 
Compared to the low-risk cohort, the incidence of adverse events was significantly higher in the 
alcohol-dependence cohort (48.3% vs. 28.1%, p=0.007) but similar in at-risk patients (27.5%, 
p=0.970).  After adjustment for age and gender, the odds of an adverse event occurring were 2.65 
greater (CI 1.29-5.46, p=0.008) in an alcohol dependent patient compared to low-risk patient (Table 
2). 
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Agitation & Sedation Scores 
A total of 7731 Bloomsbury sedation scores were collected over 2203 patient study days (mean 3.5 
scores per patient day) with no significant differences in number of scores collected between 
cohorts (p=0.320). Patients in the low-risk group were 'optimally sedated' (scores 0-2 or 'natural 
sleep') 74.9% of the time, compared to 65.2% in the at-risk cohort (p<0.001) and 62.8% in the 
alcohol-dependent cohort (p<0.001) (Fig.1). Compared to the low-risk group, alcohol dependent 
patients showed a predisposition to lower conscious levels, with sedation scores of -3 to -1 (19.2% 
vs. 13.3%, p<0.001). Overall, patients in the at-risk cohort (21.6% of scores) and alcohol dependence 
cohort (17.8%) were more frequently 'agitated and restless' than low-risk patients (11.4%, p<0.001). 
It should be noted, however, that 38.7% (n=128) of all 'agitated & restless' scores for the at-risk 
cohort came from one patient (representing 39.4% of their scores). 
Delirium 
The overall incidence of delirium was 53.7% (138 of 257 patients).  Incidence of delirium was 
significantly higher in the alcohol-dependence cohort (Table 3) compared to low-risk patients (68.3% 
vs. 48.4%, p=0.041), but not  in the at-risk cohort (50.7%, p=0.865). On multivariate analysis, alcohol-
dependent patients were 3.28 times (OR CI 1.38-7.79, p=0.007) more likely to develop delirium 
compared to low-risk patients (Table 4). Duration of delirium was significantly longer in the alcohol-
dependence group compared to the low-risk group (5 vs. 3 days, p=0.005).  
As patients with alcohol dependency were found to be at a significantly increased risk of delirium, 
possible factors related to delirium were entered into univariate and multivariate analysis to identify 
possible risk factors for this population (Appendix). Cumulative dose of morphine equivalents, 
lorazepam equivalents and number of sedative drugs were associated with an increased risk of 
delirium on univariate analysis, with total LOS (OR 1.13 CI 1.00-1.27, p=0.043) and a diagnosis of 
sepsis (OR 5.07 CI 1.12-23.01, p=0.036) remaining as significant risk factors on multivariate analysis. 
Sedation 
Characteristics of Sedation 
Patients with alcohol-dependence received a mean of 3.2 different sedatives during their stay, 
significantly more than the low-risk cohort (3.2 vs. 2.6, p=0.019). However, the at-risk cohort 
received a similar variety of sedation compared to the low-risk cohort (2.3 vs. 2.6, p=0.178). Alcohol 
dependent patients did not require third line sedatives more often than low-risk patients. 
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Alcohol-dependent patients were significantly more likely to receive benzodiazepines (OR 1.67 CI 
1.16-2.39, p=0.005) and haloperidol (OR 1.51 CI 1.02-2.24, p=0.040), but were no more likely to 
receive propofol or opioids. Patients in the at-risk cohort were significantly less likely to receive 
opioids than low-risk patients (OR 0.29 CI 0.14-0.58, p=0.001), but were no more likely to receive 
benzodiazepines, propofol or haloperidol. 
Dosages of Sedatives 
Adjusting for age and gender, alcohol-dependent patients received similar mean daily dosages for all 
drugs except alfentanil, where these patients used less (OR 0.84, CI 0.74-0.94, p=0.004), compared 
to low-risk patients. Despite receiving significantly more propofol and benzodiazepines on univariate 
analysis, adjusting for age and gender, patients in the at-risk cohort received similar doses for all 
sedatives compared to low-risk patients (Table 4). 
Discussion 
Agitation   
Our 55.6% estimate of the incidence of agitation in ICU patients resembles previous findings [18]. 
However, across the literature agitation varies considerably, likely due to varying definitions [13] 
[23]. Our population is at increased risk. Agitation has previously been identified as an independent 
risk factor for self-extubation, and this is reflected in our finding that alcohol dependent patients are 
significantly more likely to experience an adverse event in ICU compared to patients with no alcohol 
issues. Hence, modulating agitation in these higher risk patients could reduced rates of adverse 
events such as self-extubation and falls. [24] Our findings also indicate that although the incidence of 
agitation is not significantly elevated in 'at-risk' patients, in those who do exhibit agitation, it 
occupies a substantial proportion of patient days. 
 
In our population, whilst patients had favourable levels of sedation for the majority of the time, both 
alcohol subgroups exhibited substantially more time 'agitated and restless'. We also found that 
alcohol-dependent patients are more difficult to maintain in an aroused and cooperative state and 
hence, are more likely to become over-sedated. There is greater tendency to sub-optimal sedation, 
with scores indicating over-sedation and agitation both more frequent than in low-risk patients. 
These results are consistent with a similar analysis of much smaller study by de Wit et al[25].  
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Delirium 
As for agitation, estimates for the incidence of delirium in critically ill patients show considerable 
variability depending upon the population studied and the diagnostic criteria utilised. Our estimate 
of 53.7% is consistent within these parameters. With regards to delirium in AUD patients, only two 
studies have previously evaluated the role of alcohol in the development of  delirium in ICU patients, 
with both identifying it as a significant risk factor[26] [27]. Both previous studies had extremely 
conservative definitions of alcohol intake. Our study goes further in suggesting that alcohol 
dependent patients are at greatest risk, whilst at-risk drinkers have a similar risk to baseline. 
Sedation 
Our findings show that alcohol-dependent patients were significantly more likely to receive 
benzodiazepines and haloperidol than patients with no alcohol issue but were no more likely to 
receive opioids or propofol. The increased prescription of benzodiazepines in this cohort is 
potentially attributable to its use in the treatment of AWS. However, benzodiazepines have 
deliriogenic properties and particularly in AUD patients with liver cirrhosis the effects of diazepam 
can be perpetuated due to its long half-life[28]. Consequently, lorazepam may be preferable in this 
situation due to its more rapid hepatic metabolism to inactive lorazepam glucuronide. Daily dose of 
haloperidol was similar across all cohorts, most probably due to standardised protocols governing its 
prescription in our unit.  
 
Patients in the alcohol dependent cohort required significantly lower dosages of alfentanil. Similar 
findings were documented by Karir et al who found that ICU patients with alcohol dependency 
required significantly less opioids but similar propofol doses, compared to patients with no alcohol 
issues.[29] The physiological basis for this may be due to altered clearance of the drug in alcohol 
dependency or hepatic encephalopathy with altered drug metabolism. The liver is the main site of 
metabolism for most opioids via the CYP and glucuronidation pathways which can both become 
impaired in liver disease, resulting in a reduction in dose of opioid required for equivalent effect[30;, 
31].  
Indeed, 60% of patients in the alcohol-dependence cohort had liver disease compared to 5.8% and 
3.1%, respectively, in the at-risk and low-risk cohorts. The greater variance in daily dosing of 
propofol and benzodiazepines amongst alcohol-dependents could be attributed to the potential for 
diverse presentations of encephalopathy.  
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Strengths & Limitations 
This service evaluation had a number of strengths. Identification of patients and stratification into 
risk categories were prospectively defined and the sample size was sufficiently large enough to 
identify differences between cohorts. This project also had limitations. We utilised a retrospective 
design, with definitions of agitation and delirium applied to a prospectively collected database. Our 
sample was limited to a single-centre ICU, which serves a relatively deprived area of Glasgow. 
Therefore, our population may differ from others which may limit its external validity. It would have 
been preferable to match for age and sex in addition to APACHE-II and sepsis, although due to the 
constraints of the pool of low-risk patients available for matching, this was not possible. Due to the 
incidence of CAM-ICU scoring in our unit at the time of data-extraction being low, the chart-
screening method was used as the primary source. Although it has been shown that this method has 
reasonable research efficacy in the ICU setting, it has reduced accuracy compared to prospective 
collection of CAM-ICU scores and as such, this method is associated with a degree of subjectivity. 
Additionally, it was also more difficult to accurately identify patients with hypoactive delirium using 
this method, so we may have underestimated the incidence of delirium in our cohort, as hyperactive 
delirium would be more readily recognised. 
 
Conclusions 
 
Our analysis demonstrates that alcohol dependent patients, rather than at-risk drinkers have a 
significantly increased risk of agitation, delirium and sub-optimal sedation in ICU. These findings 
highlight the need for concerted efforts to diagnose and actively manage agitation and delirium 
particularly in those with alcohol dependency. 
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